Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors.
作者信息
Xia Zhijia, Chen Shi, He Miao, Li Benhua, Deng Yayuan, Yi Lin, Li Xiaosong
机构信息
Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.
Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
出版信息
Front Immunol. 2023 Jul 27;14:1247178. doi: 10.3389/fimmu.2023.1247178. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors.社论：靶向代谢以激活T细胞并增强实体瘤中检查点阻断免疫疗法的疗效
Front Immunol. 2023 Jul 27;14:1247178. doi: 10.3389/fimmu.2023.1247178. eCollection 2023.
2
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.通过阻断免疫检查点TIGIT/PVR的相互作用重新定位甲状腺素用于癌症免疫治疗。
Cell Commun Signal. 2020 Sep 7;18(1):142. doi: 10.1186/s12964-020-00638-2.
3
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.IL-15 预处理增强了 CAR T 细胞对检查点阻断的反应，以改善实体瘤的治疗效果。
Mol Ther. 2020 Nov 4;28(11):2379-2393. doi: 10.1016/j.ymthe.2020.07.018. Epub 2020 Jul 21.
4
Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy.靶向 T 细胞代谢以增强免疫检查点抑制剂治疗。
Front Immunol. 2022 Dec 7;13:1046755. doi: 10.3389/fimmu.2022.1046755. eCollection 2022.
5
The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.免疫检查点抑制剂在结直肠癌治疗中的出现。
Curr Drug Targets. 2021;22(9):1021-1033. doi: 10.2174/1389450122666210204204415.
6
Alternative Checkpoints as Targets for Immunotherapy.免疫疗法的替代检查点靶点。
Curr Oncol Rep. 2020 Nov 3;22(12):126. doi: 10.1007/s11912-020-00983-y.
7
Targeting immune checkpoints in hematological malignancies.靶向血液系统恶性肿瘤的免疫检查点。
J Hematol Oncol. 2020 Aug 12;13(1):111. doi: 10.1186/s13045-020-00947-6.
8
Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).靶向免疫检查点分子的纳米抗体用于肿瘤免疫治疗和免疫成像（综述）。
Int J Mol Med. 2021 Feb;47(2):444-454. doi: 10.3892/ijmm.2020.4817. Epub 2020 Dec 14.
9
Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy.胸腺功能和 T 细胞受体库多样性：对患者对检查点阻断免疫治疗反应的影响。
Front Immunol. 2021 Nov 24;12:752042. doi: 10.3389/fimmu.2021.752042. eCollection 2021.
10
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.CARM1 抑制通过对肿瘤细胞和 T 细胞的双重作用使耐药肿瘤的免疫治疗成为可能。
Cancer Discov. 2021 Aug;11(8):2050-2071. doi: 10.1158/2159-8290.CD-20-1144. Epub 2021 Mar 11.
引用本文的文献
1
Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.肿瘤浸润淋巴细胞和三级淋巴结构在胃癌进展中的作用与功能。
Front Immunol. 2025 May 29;16:1595070. doi: 10.3389/fimmu.2025.1595070. eCollection 2025.
2
Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets.胰腺癌中的免疫抑制性肿瘤微环境：机制与治疗靶点
Front Immunol. 2025 May 15;16:1582305. doi: 10.3389/fimmu.2025.1582305. eCollection 2025.
3
Immunotherapeutic strategies for invasive bladder cancer: a comprehensive review.浸润性膀胱癌的免疫治疗策略：综述
Front Immunol. 2025 Apr 30;16:1591379. doi: 10.3389/fimmu.2025.1591379. eCollection 2025.
4
Metabolic reprogramming and immune microenvironment characteristics in laryngeal carcinoma: advances in immunotherapy.喉癌中的代谢重编程与免疫微环境特征：免疫治疗进展
Front Immunol. 2025 Apr 30;16:1589243. doi: 10.3389/fimmu.2025.1589243. eCollection 2025.
5
Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications.肝细胞癌中的代谢重编程：免疫逃逸机制及治疗意义
Front Immunol. 2025 Apr 30;16:1592837. doi: 10.3389/fimmu.2025.1592837. eCollection 2025.
6
The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients.癌症相关成纤维细胞的恶性特征基因可作为结肠腺癌患者潜在的预后生物标志物。
Front Immunol. 2025 Apr 17;16:1589678. doi: 10.3389/fimmu.2025.1589678. eCollection 2025.
7
The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells.调节性T细胞在结直肠癌中的作用及针对调节性T细胞的免疫治疗
Front Immunol. 2025 Apr 16;16:1574327. doi: 10.3389/fimmu.2025.1574327. eCollection 2025.
8
Causal association between immune cell phenotypes and colorectal cancer: a two-sample bidirectional Mendelian randomization analysis.免疫细胞表型与结直肠癌之间的因果关联：一项两样本双向孟德尔随机化分析
Discov Oncol. 2025 Apr 29;16(1):638. doi: 10.1007/s12672-025-02443-0.
9
Acute aerobic exercise alters serum protein distribution in colorectal cancer patients.急性有氧运动改变结直肠癌患者的血清蛋白分布。
Front Oncol. 2025 Apr 9;15:1586344. doi: 10.3389/fonc.2025.1586344. eCollection 2025.
10
The role of tumor-associated macrophages in HPV induced cervical cancer.肿瘤相关巨噬细胞在人乳头瘤病毒诱导的宫颈癌中的作用。
Front Immunol. 2025 Apr 8;16:1586806. doi: 10.3389/fimmu.2025.1586806. eCollection 2025.
本文引用的文献
1
A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.一种基于癌相关成纤维细胞的新型标志物可预测肺腺癌的预后和免疫治疗反应。
Front Immunol. 2023 May 31;14:1201573. doi: 10.3389/fimmu.2023.1201573. eCollection 2023.
2
Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT.胰腺癌中癌症相关成纤维细胞的代谢重编程促成了PET-CT的肿瘤内异质性。
Comput Struct Biotechnol J. 2023 Apr 7;21:2631-2639. doi: 10.1016/j.csbj.2023.04.003. eCollection 2023.
3
Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.鞘脂标志物的预后特征：了解免疫图谱及其在预测肝癌免疫治疗反应和结局中的作用。
Front Immunol. 2023 Mar 17;14:1153423. doi: 10.3389/fimmu.2023.1153423. eCollection 2023.
4
Metabolic plasticity and regulation of T cell exhaustion.T 细胞耗竭的代谢可塑性和调控。
Immunology. 2022 Dec;167(4):482-494. doi: 10.1111/imm.13575. Epub 2022 Sep 30.
5
Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells.重编线粒体代谢以对抗 CAR-T 细胞耗竭。
J Hematol Oncol. 2022 Mar 28;15(1):38. doi: 10.1186/s13045-022-01255-x.
6
Prosurvival IL-7-Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1-TCF1-Id3 and Metabolic AMPKα1-ULK1-ATG7 Pathways.IL-7 刺激的生存促进弱 mTORC1-S6K 力量通过转录 FOXO1-TCF1-Id3 和代谢 AMPKα1-ULK1-ATG7 途径控制 T 细胞记忆。
J Immunol. 2022 Jan 1;208(1):155-168. doi: 10.4049/jimmunol.2100452. Epub 2021 Dec 6.
7
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies.细胞代谢途径在血液系统恶性肿瘤发病机制及选择性治疗中的重要性
Front Oncol. 2021 Nov 10;11:767026. doi: 10.3389/fonc.2021.767026. eCollection 2021.
8
IL-33 activates mTORC1 and modulates glycolytic metabolism in CD8 T cells.IL-33 激活 mTORC1 并调节 CD8 T 细胞的糖酵解代谢。
Immunology. 2022 Jan;165(1):61-73. doi: 10.1111/imm.13404. Epub 2021 Aug 31.
9
Interleukin-34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony-Stimulating Factor Receptor.白细胞介素 34 通过 syndecan 1 和巨噬细胞集落刺激因子受体重编程糖酵解和破骨细胞类风湿关节炎巨噬细胞。
Arthritis Rheumatol. 2021 Nov;73(11):2003-2014. doi: 10.1002/art.41792. Epub 2021 Sep 22.
10
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation.IL-23 和 IL-1β 在缺乏 CD28 共刺激的情况下驱动人 Th17 细胞分化和代谢重编程。
Cell Rep. 2018 Mar 6;22(10):2642-2653. doi: 10.1016/j.celrep.2018.02.044.
Zotero 插件